Benefit-Risk Assessment of Bevacizumab i
β
Rodrigo Dienstmann, Felipe Ades, Kamal S. Saini, Otto Metzger-Filho
π
Article
π
2012
π
Springer International Publishing AG
π
English
β 143 KB